NDC 50242-076 Nutropin Aq Nuspin 20
Somatropin Injection, Solution Subcutaneous - View Dosage, Usage, Ingredients, Routes, UNII
Product Information
- 50242 - Genentech, Inc.
- 50242-076 - Nutropin Aq Nuspin 20
Product Packages
NDC Code 50242-076-01
Package Description: 1 CARTRIDGE in 1 CARTON / 2 mL in 1 CARTRIDGE
Product Details
What is NDC 50242-076?
What are the uses for Nutropin Aq Nuspin 20?
What are Nutropin Aq Nuspin 20 Active Ingredients?
- SOMATROPIN 20 mg/2mL - A 191-amino acid polypeptide hormone secreted by the human adenohypophysis (PITUITARY GLAND, ANTERIOR), also known as GH or somatotropin. Synthetic growth hormone, termed somatropin, has replaced the natural form in therapeutic usage such as treatment of dwarfism in children with growth hormone deficiency.
Which are Nutropin Aq Nuspin 20 UNII Codes?
The UNII codes for the active ingredients in this product are:
- SOMATROPIN (UNII: NQX9KB6PCL)
- SOMATROPIN (UNII: NQX9KB6PCL) (Active Moiety)
Which are Nutropin Aq Nuspin 20 Inactive Ingredients UNII Codes?
The inactive ingredients are all the component of a medicinal product OTHER than the active ingredient(s). The acronym "UNII" stands for “Unique Ingredient Identifier” and is used to identify each inactive ingredient present in a product. The UNII codes for the inactive ingredients in this product are:
- SODIUM CHLORIDE (UNII: 451W47IQ8X)
- PHENOL (UNII: 339NCG44TV)
- POLYSORBATE 20 (UNII: 7T1F30V5YH)
- SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)
What is the NDC to RxNorm Crosswalk for Nutropin Aq Nuspin 20?
- RxCUI: 1735494 - somatropin 20 MG in 2 ML Pen Injector
- RxCUI: 1735494 - 2 ML somatropin 10 MG/ML Pen Injector
- RxCUI: 1735494 - somatropin 20 MG per 2 ML Pen Injector
- RxCUI: 1735496 - Nutropin AQ 20 MG in 2 ML Pen Injector
- RxCUI: 1735496 - 2 ML somatropin 10 MG/ML Pen Injector [Nutropin]
Which are the Pharmacologic Classes for Nutropin Aq Nuspin 20?
* Please review the disclaimer below.
Patient Education
Somatropin
Somatropin injection is used to replace growth hormone (a natural hormone produced by your body) in adults and children with growth hormone deficiency. Somatropin injection is also used to increase growth in children with certain conditions that affect normal growth and development. Somatropin injection (Serostim) is used to increase body weight and physical endurance in patients with human immunodeficiency virus (HIV) who have HIV-associated wasting syndrome. Somatropin injection (Zorbtive) is used to treat short bowel syndrome in adults who are receiving additional nutrition or fluids from intravenous (IV) therapy. Somatropin is a human growth hormone (hGH) analog. It works by replacing growth hormones that are normally produced in the body, which may result in increased growth, body weight, and improved absorption of nutrients and fluids from the intestines.
[Learn More]
* Please review the disclaimer below.
[1] What is the Non-Proprietary Name? - The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
[2] What is the Substance Name? - An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
[3] What kind of product is this? - Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
[4] What are the Administration Routes? - The translation of the route code submitted by the firm, indicating route of administration.
[5] What is the Labeler Name? - Name of Company corresponding to the labeler code segment of the Product NDC.
[6] What is the FDA Application Number? - This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null.
[8] What is the Marketing Category? - Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
[9] What is the Start Marketing Date? - This is the date that the labeler indicates was the start of its marketing of the drug product.
[11] What is the Listing Expiration Date? - This is the date when the listing record will expire if not updated or certified by the product labeler.
[12] What is the NDC Exclude Flag? - This field indicates whether the product has been removed/excluded from the NDC Directory for failure to respond to FDA"s requests for correction to deficient or non-compliant submissions ("Y"), or because the listing certification is expired ("E"), or because the listing data was inactivated by FDA ("I"). Values = "Y", "N", "E", or "I".